NOOSPHERE

Fichas públicas de documentos

Referencias bibliográficas de procedencia pública y con enlaces estables. El catálogo no incluye todos los documentos del corpus ni reproduce sus textos completos.

98,186 fichas públicas · página 73 / 982

  1. The summary of crucial issues in current anammox application.2026 · PubMed
  2. The sustainability-convenience paradox: ritualized coffee consumption among Generation Z consumers2026 · Crossref
  3. The Sustainable Phytoremediation of Lead and Cadmium using Cannabis Species: A comparative review of the detoxification ability2026 · Crossref
  4. The Symbiotic Cycle of Creativity: three diagrams mapping scope of care and the psychedelic threshold in design2026 · OpenAlex
  5. The The Role of CR on PD Customer in Local F&B Applications: An Empirical Study of Fore Coffee, Jiwa+ by Kopi Janji Jiwa, Tomoro Coffee, Boga App dan Kopi Kenangan Indonesia2026 · Crossref
  6. The Therapeutic Alliance's Moderating Role on the Negative Relationship Between Dread of Ego Dissolution and Changes in Depression Symptom Severity in Psilocybin-Assisted Therapy for Treatment-Resistant Depression: A Secondary Analysis of the PsiDeR Trial.2026 · OpenAlex
  7. The Therapeutic Effect of Methylphenidate Hydrochloride in Conjunction with Sensory Integration Training in Children with Attention Deficit Hyperactivity Disorder2026 · Crossref
  8. The therapeutic effect of nicotinamide riboside chloride on ameliorating alcohol-induced neuronal damage with a focus on mitochondrial unfolded protein response and mitophagy.2026 · PubMed
  9. The therapeutic landscape of cannabidiol: a systematic review of molecular mechanisms, clinical efficacy in oncology and neurology, and regulatory changes2026 · Crossref
  10. The therapeutic management of comorbid bipolar disorder and substance use disorder in female patients: our protocols and review of literature2026 · Crossref
  11. The therapeutic potential of ayahuasca in depression, generalized anxiety, and substance use disorders: modulation of the depressive burden in a longitudinal study2026 · OpenAlex
  12. The Therapeutic Potential of Psychedelics for Treatment-resistant Depression2026 · Crossref
  13. The toxicity of psychedelic LSD derivatives: 1-acetyl-LSD (ALD-52), 1-propionyl-LSD (1P-LSD), 1-butyryl-LSD (1B-LSD), 1-valeryl-LSD (1V-LSD) and 1-cyclopropylmethanoyl-LSD (1cP-LSD)-prediction of toxicological parameters relevant to clinical and forensic toxicology using multi-in silico approach.2026 · PubMed
  14. The toxicology and characteristics of fatal new psychoactive stimulant and hallucinogen-related poisonings in Australia, 2000-2025.2026 · PubMed
  15. The transcription factor LSD-one-like 2 binds to a novel identified cis-element LBE (GCCAAAAC) and regulates molecular response of Populus davidiana×P. bolleana to salt stress.2026 · PubMed
  16. THE TRANSITION TO A MIXED SYSTEM OF SPIRITUOUS BEVERAGES TRADE IN THE 1780S: EXPECTATIONS, RESULTS, AND CONSEQUENCES (THE CASE OF THE MOSCOW REGION)2026 · Crossref
  17. The Téchne of the 21st Century Transgressive Laughter: Stiob, Holy Foolishness, Rock Counterculture and Carnivalesque Trolling2026 · Crossref
  18. The Uneven Origins of Eco-Consciousness in the First Psychedelic Revolution2026 · OpenAlex
  19. THE UNIFIED SENSING FRAMEWORK2026 · OpenAlex
  20. The Unspoken Shift: Menopause, Mental Health, and Substance Use in Black Women2026 · Crossref
  21. THE USE OF CANNABIDIOL IN THE TREATMENT OF AUTISM SPECTRUM DISORDER2026 · Crossref
  22. The use of cannabis for medical reasons in the UK: Prescriptions, sources, products, and high-risk use2026 · Crossref
  23. The use of drug checking legislation to facilitate illicit drug consumption research: psychedelic microdosing as a case example2026 · Crossref
  24. The Use of Lycium barbarum Polysaccharides to Control Liver Disease: A Review2026 · Crossref
  25. The Use of Medical Marijuana Versus Opiates in Chronic Non-Cancer Pain2026 · Crossref
  26. The Use of Monoclonal Antibodies of IgG and IgM Classes to Monitor β-D-Glucan Production from Basidiomycete Mushroom Strains in Agro-Industrial Wastes2026 · Crossref
  27. The Use of Psilocybin for Managing Refractory Behavioral Health Conditions: A Narrative Review2026 · Crossref
  28. The Use of Psychedelics in the Treatment of Adult ADHD: A Systematic and Mechanistic Review.2026 · PubMed
  29. The Validation of the Revised Illness Perception Questionnaire in Cancer Patients: An Exploratory Factor Analysis for Further Psychometric Evidence2026 · Crossref
  30. The Victims of Drug Trafficking from A Transitional Justice Approach2026 · Crossref
  31. The Victoria SAFER initiative: A community-based prescribed safer supply program using fentanyl formulations in Victoria, BC.2026 · PubMed
  32. The Virtual Feedback Loop: Psychometric Validation of a New Scale to Measure Digital Validation Seeking in Higher Education2026 · Crossref
  33. The working lives of neuronal 5-HT<sub>2A</sub> receptors from the outside in.2026 · PubMed
  34. The α1 subunit-containing GABA<sub>A</sub> receptor-mediated inhibitory transmission in the lateral orbitofrontal cortex contributes to anxiety- and depression-like behaviors in Parkinsonian rats.2026 · PubMed
  35. The “dark magic mushroom” co-produces amatoxins and psilocybin2026 · OpenAlex
  36. Theka Coffee – Indian startup with the internationalization dilemma2026 · Crossref
  37. Theoretical Frameworks to Guide Education on Care of Mothers With Substance Use Disorder: A Narrative Review2026 · Crossref
  38. Theoretical investigation of fast illicit drug detection via ternary photonic crystals2026 · Crossref
  39. Theories and Practices on Developing Various Models of Betel Quid Cessation in Taiwan2026 · Crossref
  40. Theorizing causality: A qualitative study of xylazine-related wound diversity and perceived etiology among people who inject drugs.2026 · PubMed
  41. Therapeutic advances in fibromyalgia: one year in review 2026.2026 · PubMed
  42. Therapeutic effectiveness of group psychotherapy incorporating cognitive and goal management training in substance use disorder patients under deferred prosecution2026 · Crossref
  43. Therapeutic effects of psilocybin in major depressive disorder: a systematic review and meta-analysis exploring dose effects.2026 · PubMed
  44. Therapeutic modulation of the gut-brain axis in alcohol use disorder: A systematic review.2026 · PubMed
  45. Therapeutic potential of acidic cannabinoids: an update2026 · Crossref
  46. Therapeutic potential of cannabidiol supplementation in mitigating lipid precursors of inflammation in hepatic steatosis progression2026 · Crossref
  47. Therapeutic potential of classic and non-classic psychedelics in neurodevelopmental disorders: Opportunities and challenges.2026 · PubMed
  48. Therapeutic Potential of Classical Psychedelics and NonHallucinogenic Psychoplastogens in Psychiatric Disorders2026 · Crossref
  49. Therapeutic potential of CMPP, a novel maleimide derivative, in a reserpine-induced mouse model of pain-depression dyad.2026 · PubMed
  50. THERAPEUTIC POTENTIAL OF DATURA METEL IN WOUND HEALING: A COMPREHENSIVE REVIEW2026 · OpenAlex
  51. Therapeutic potential of harmine in polycystic ovarian syndrome: regulation of TNF-α/IL-6-mediated inflammation, Nrf2/keap-1 signaling, and ovarian steroidogenesis in Sprague-Dawley rats.2026 · PubMed
  52. Therapeutic potential of neem (Azadirachta indica) and hemp (Cannabis sativa) soil amendments for the sustainable management of root-knot nematodes (Meloidogyne incognita) in tomato2026 · Crossref
  53. Therapeutic Potential, Predictive Pharmaceutical Modeling, and Metabolic Interactions of the Oxindole Kratom Alkaloids2026 · OpenAlex
  54. Therapeutic properties of ayahuasca component N,N-Dimethyltryptamine in a pre-clinical model of Parkinson's disease2026 · OpenAlex
  55. Therapeutic properties of ayahuasca component N,N-Dimethyltryptamine in a pre-clinical model of Parkinson's disease.2026 · PubMed
  56. Therapeutic relevance of an EU-GMP certified Cannabis sativa L. strain in a dual in vivo model of cognitive impairment and chronic neuropathic pain2026 · Crossref
  57. Therapeutic Use of Cannabis: Knowledge and Acceptance among Citizens of Trujillo, Peru2026 · Crossref
  58. Therapeutic uses, pharmacological and clinical importance of Cannabis sativa: a review article2026 · OpenAlex
  59. Therapeutically Motivated Cannabis Use for Anxiety: Daily and Longitudinal Reductions Vary Between Flower and Edible Products2026 · Crossref
  60. Therapist Manual for Psilocybin-Assisted Therapy of Treatment-Resistant Major Depression2026 · OpenAlex
  61. These aren’t the beliefs you’re looking for: on the limits of affect-neutral accounts of psychedelic therapy2026 · OpenAlex
  62. Thiamine Deficiency in Hospitalized Veterans Without Alcohol Use Disorder: Prevalence, Biomarker Assessment, and Clinical Characteristics2026 · Crossref
  63. Thinking beyond blood: Brain concentrations and brain-blood ratios in postmortem toxicology2026 · Crossref
  64. Thirty Years of Ibogaine Research: A Literature Review on Clinical Perspectives.2026 · PubMed
  65. This is my way of Drinking: A Scoping Review of how Individuals Narrate Their Alcohol-Related Problems2026 · Crossref
  66. This Is Your Brain on Drugs: A Review of Chris Letheby’s Philosophy of Psychedelics2026 · OpenAlex
  67. Thoracic paravertebral block with different doses of liposomal bupivacaine versus ropivacaine for postoperative analgesia in single-port thoracoscopic lung surgery: a randomized clinical trial.2026 · PubMed
  68. Threat Sensitivity, Stress, and Alcohol Use in Probable PTSD: Findings from a Mobile Attention Bias Modification Trial2026 · Crossref
  69. Three cases of wood-lover paralysis: clinical insights from Victoria, Australia.2026 · PubMed
  70. Three closely linked X‐chromosomal genes potentially control sex determination in Cannabis sativa2026 · Crossref
  71. Three State-Level Tobacco Control Policies to Address Vaping Among Young People and Changes in Vaping Product Access and Use, Vermont, 2019-20212026 · Crossref
  72. Three-year cardiovascular risk prediction among people who use cocaine or methamphetamine.2026 · PubMed
  73. Through the haze: a multinational cross-sectional comparison of cannabis risk knowledge gaps among young adults2026 · Crossref
  74. Through the haze: how the tobacco control community in New Zealand influenced policy change2026 · Crossref
  75. Through the Looking-Glass: A Scoping Review of Psychological Mechanisms of Psychedelic-Assisted Therapy for Substance Use Disorders2026 · OpenAlex
  76. Tianeptine misuse and addiction: A systematic review of withdrawal, toxicity, and clinical management.2026 · PubMed
  77. Time for tailored harm reduction focus on new initiates to injecting drug use.2026 · PubMed
  78. Time matters for metas: a systematic review and meta-analysis of ect vs ketamine for depression incorporating time2026 · OpenAlex
  79. Time to embrace the whole: considering the replacement of psilocybin with <i>Psilocybe</i> spp. in psychedelic research and therapy.2026 · PubMed
  80. Time Trends and Co-evolution Patterns of Adolescent Risk Behaviors by Gender : An Exploratory Analysis Based on Korea Youth Risk Behavior Survey Data (2022~2025)2026 · Crossref
  81. Time Windows Used When Identifying Current Drug Use and Polypharmacy2026 · Crossref
  82. Time-dependent effects of rapid-acting antidepressants in iPSC-derived neurons from treatment-resistant depression and healthy volunteers.2026 · PubMed
  83. Time-of-Day Effects of Platelet-Derived Exosomes on Cognitive-Emotional Functions in an Animal Model of Methamphetamine Addiction.2026 · PubMed
  84. Time-resolved Neural and Experience Dynamics of Medium- and High-dose N,N-Dimethyltryptamine (DMT).2026 · OpenAlex
  85. Tissue-retained needles in people who inject drugs: A systematic review of case reports and series on clinical presentations, complications and management.2026 · PubMed
  86. To Assess if Prescribing Psychotropic Medication for Patients With Personality Disorder Diagnosis in the Absence of Any Other Psychiatric Comorbidities, Improves the Clinical Outcome2026 · Crossref
  87. Tobacco advertising, cross-over effects, and US adolescent progression from never to current tobacco use2026 · Crossref
  88. Tobacco and Cannabis Use Disorders: Similarities, Differences and Therapeutic Approaches2026 · Crossref
  89. Tobacco and cannabis use in the young ‘Not in Employment, Education or Training’ population: A systematic review and meta‐analysis2026 · Crossref
  90. Tobacco and Opium Use and Risk of Liver and Colorectal Cancer Mortality: Analysis of the Golestan Cohort Study2026 · Crossref
  91. Tobacco and Public Health in Rajasthan: A Stakeholder Perspective on Commercial Determinants2026 · Crossref
  92. Tobacco as a Carcinogen: Correlating Exposure History with Lung and Oral Cavity Malignancies — A Two-Year Retrospective Histopathological Study at a Tertiary Care Centre2026 · Crossref
  93. Tobacco cessation training for undergraduate dental students: a systematic review2026 · Crossref
  94. Tobacco cessation treatment in pregnancy: insights from Florida Medicaid claims data2026 · Crossref
  95. Tobacco control without cessation? Policy gaps in cessation services in Bangladesh.2026 · PubMed
  96. Tobacco harm reduction for people experiencing homelessness: a qualitative study of lived experiences and service provider perspectives2026 · Crossref
  97. Tobacco Harm Reduction in European Prisons: Snus as a Case Study for Addressing Future Physical Health Challenges2026 · Crossref
  98. Tobacco industry interference and WHO FCTC Article 5.3 implementation in Aotearoa New Zealand: A qualitative analysis2026 · Crossref
  99. Tobacco Industry’s Corporate Diversification in the Evolving Landscape of Tobacco Control Laws in India – A Comparative Time-Series Analysis2026 · Crossref
  100. Tobacco industry’s political contributions in conflict with WHO FCTC Article 5.3 Guidelines: an analysis of publicly available documents from India2026 · Crossref